New US Policy On SEP Remedies Restores Critical Balance

Law360 (March 19, 2020, 5:40 PM EDT) -- In January 2013, the U.S. Department of Justice's Antitrust Division and the U.S. Patent and Trademark Office issued a joint policy statement that has generally been interpreted to limit the availability of injunctive relief for infringement of standard-essential patents subject to fair, reasonable and nondiscriminatory licensing assurances.

In December 2019, the agencies, joined this time by the National Institute of Standards and Technology, backed away from the 2013 statement and clarified that FRAND-assured SEPs are governed by the same set of rules as other patents and that remedies, including injunctions, are available as appropriate under the general framework of substantive remedies...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!